31 results
Management of adult IgA Vasculitis (Henoch-Schönlein purpura) - Treatment algorithm for the management of IgAV patients
Management of adult ... IgA Vasculitis ... Henoch-Schönlein purpura) - Treatment ... Treatment remains ... #Treatment #Rheumatology
Salter Harris Fractures - Pediatric Fractures of the Physis 
SALTR Mnemonic 

Salter Harris I 
Straight through
Harris Fractures - Pediatric ... Displacement dictates treatment ... ortho treatment ... ortho treatment ... Orthopedics #Diagnosis #Management
Tetralogy of Fallot Summary
 • Anatomy
 • Incidence
 • Pathophysiology
 • Presentation
 • Common Variants
 •
palliation • Post-Op Management ... Fallot #diagnosis #management ... cardiology #peds #pediatrics ... #treatment
Cor triatriatum
 • Epidemiology
 • Etiology
 • Associated Lesions
 • Differentials Diagnosis
 • Anatomy - Sinister,
Diagnosis • Treatment ... Post-Operative Management ... CorTriatriatum #diagnosis #management ... summary #peds #pediatrics
Alzheimer's Disease - Summary
 • Epidemiology
 • Pathophysiology
 • Risk Factors
 • Presentation
 • Diagnosis
 •
Diagnosis • Treatment ... Summary #diagnosis #management ... #geriatrics
Pediatric SVT - Management Algorithm
Identify SVT:
 • HR not variable
 • Abrupt rate changes
 • Infants:
Pediatric SVT - ... Management Algorithm ... #tachycardia #Management ... Algorithm #peds #Pediatric ... #treatment
Status Epilepticus - Management
Seizure > 5 mins or two seizures without complete recovery between them
PEDS
Benzo Dose
Epilepticus - Management ... Epilepticus #seizures #management ... #treatment #algorithm ... #peds #pediatrics
Treatment Schema for Standard-Risk Acute Lymphoblastic Leukemia
Induction: 
 • Vincristine, Steroid (dexamethasone), L-Asparaginase, Intrathecal (IT) methotrexate
Consolidation
Treatment Schema ... given throughout treatment ... Lymphoblastic #Leukemia #Treatment ... timeline #oncology #pediatrics ... #peds #management
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
release assay (IGRA ... Tuberculosis Treatment ... Initiating Treatment ... TB #Diagnosis #Management ... #Treatment #ActiveTB
Patient factors influencing the selection Of glucose-lowering drugs Other than SGLT2i and metformin in T2D and
filtration rate GLP IRA ... #CKD #Diabetes Management ... in CKD #management ... #treatment #CHART